Serpil Ceylan Hoca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Serpil Ceylan Hoca has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Emre Hoca
University of Health Sciences
1 shared publication - Salih Cihat Paltun
Erenköy Mental Health and Neurological Diseases Hospital, Istanbul, Türkiye
1 shared publication - Ubeyd Turgut Demirel
Marmara University
1 shared publication
Latest Publications
- 7 October 2026
- Published by Taylor & Francis in Postgraduate Medicine
- p. 1-10
Metabolic pathways are associated with increased estimated cardiovascular risk in major depressive disorder: a QRISK3-based analysis
1. Major depressive disorder (MDD) is characterized by persistent depressed mood, anhedonia, fatigue, appetite changes, feelings of guilt or worthlessness, distractibility, psychomotor slowing or r...
- 7 October 2026
- Published by Taylor & Francis in Postgraduate Medicine
- p. 1-10
Metabolic pathways are associated with increased estimated cardiovascular risk in major depressive disorder: a QRISK3-based analysis
1. Major depressive disorder (MDD) is characterized by persistent depressed mood, anhedonia, fatigue, appetite changes, feelings of guilt or worthlessness, distractibility, psychomotor slowing or r...
- 1 July 2025
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 44 (3) , 304-312
The relationship between plasma uric acid levels, impulsivity and suicidality in patients diagnosed with opioid use disorder
Uric acid, the final product of purine metabolism, may indicate various mental disorders and may be associated with behavioral and clinical features due to its role in adenosine transmission and the antioxidant system. In this study, it was aimed to investigate the relationship between serum uric acid, impulsivity, and suicidality in patients with opioid use disorder. An analytical, cross-sectional study was conducted with a total of 115 participants: 62 patients diagnosed with opioid use disorder and 53 healthy controls. We performed blood tests at admission and administered the Barratt Impulsivity Scale-11, Columbia-Suicide Severity Rating Scale, Suicide Probability Scale, Structured Clinical Interview Form for DSM-5, and the Sociodemographic and Clinical Data Collection Form to the participants. Serum uric acid levels were significantly lower in the opioid use disorder group than in the healthy control group. No significant correlation was found between serum uric acid levels, suicidality, and impulsivity in the opioid use disorder group. Although there is previous research that suggested a potential link between uric acid levels, impulsivity, and suicidality, we could not find a significant correlation between uric acid levels, impulsivity, and suicidality in the opioid use disorder group. However, the possible relationship between uric acid, impulsivity, and suicidality may be masked by decreasing the effect of opioid use on uric acid levels.
- 1 July 2025
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 44 (3) , 304-312
The relationship between plasma uric acid levels, impulsivity and suicidality in patients diagnosed with opioid use disorder
Uric acid, the final product of purine metabolism, may indicate various mental disorders and may be associated with behavioral and clinical features due to its role in adenosine transmission and the antioxidant system. In this study, it was aimed to investigate the relationship between serum uric acid, impulsivity, and suicidality in patients with opioid use disorder. An analytical, cross-sectional study was conducted with a total of 115 participants: 62 patients diagnosed with opioid use disorder and 53 healthy controls. We performed blood tests at admission and administered the Barratt Impulsivity Scale-11, Columbia-Suicide Severity Rating Scale, Suicide Probability Scale, Structured Clinical Interview Form for DSM-5, and the Sociodemographic and Clinical Data Collection Form to the participants. Serum uric acid levels were significantly lower in the opioid use disorder group than in the healthy control group. No significant correlation was found between serum uric acid levels, suicidality, and impulsivity in the opioid use disorder group. Although there is previous research that suggested a potential link between uric acid levels, impulsivity, and suicidality, we could not find a significant correlation between uric acid levels, impulsivity, and suicidality in the opioid use disorder group. However, the possible relationship between uric acid, impulsivity, and suicidality may be masked by decreasing the effect of opioid use on uric acid levels.